ISSN2320-2882
Impact Factor9.17
UGC ParametersAligned
Low Cost₹1501 / $59
CrossRefDOI
ESTD2013
Peer ReviewTransparent
AccessOpen
Submission: Always Open

Paper Title

Comparative studies between clobazam and Carbamazepine

Authors

Gondaliya Isha

Keywords

Clobazam, Carbamazepine, Lennox-Gastaut syndrome, Focal seizures, Generalized Tonic-Clonic seizures, Side effect profile, Anticonvulsant therapy, Neuropharmacology.

Abstract

Epilepsy, including syndromes like Lennox-Gastaut syndrome (LGS), focal seizures, and generalized tonic-clonic seizures, requires tailored anticonvulsant therapies to optimize efficacy and minimize adverse effects. This comprehensive review compares clobazam, a 1,5-benzodiazepine that enhances GABAergic neurotransmission with reduced sedation (Sankar, 2012; Gauthier & Mattson, 2015), and carbamazepine, a sodium channel blocker effective for partial and tonic-clonic seizures but associated with enzyme induction and cutaneous risks (French, 1994; Kehoe & Haw, 2020). Drawing from pharmacological, clinical, and neuropharmacological data, the analysis evaluates their physical and chemical properties, modes of action, advantages (e.g., clobazam's long-term efficacy in LGS; carbamazepine's versatility in neuropathic pain), disadvantages (e.g., clobazam's dependence risk; carbamazepine's hematologic toxicity), side effect profiles, toxicity (including teratogenicity), withdrawal symptoms, age-specific usage, and non-anticonvulsant applications (e.g., clobazam for anxiety; carbamazepine for bipolar disorder). Findings indicate clobazam offers a favorable safety profile for refractory pediatric epilepsy (Klehm et al., 2014), while carbamazepine excels in focal seizures but demands monitoring for interactions (Marson et al., 2002). Personalized treatment, considering patient age, seizure type, and comorbidities, is recommended to enhance quality of life and adherence (Samanta, 2021; Strzelczyk & Schubert-Bast, 2022). Future research should address gaps in long-term comparative trials.

How To Cite

Choose the style your journal or department asks for, then copy it. Every version below is generated from this paper's own record.

IJCRT — journal style
"Comparative studies between clobazam and Carbamazepine", IJCRT - International Journal of Creative Research Thoughts (www.ijcrt.org), ISSN:2320-2882, Vol.13, Issue 12, page no.d394-d418, December 2025, Available :https://ijcrt.org/papers/IJCRT2512390.pdf
APA — 7th edition
Isha, G. (2025). Comparative studies between clobazam and Carbamazepine. International Journal of Creative Research Thoughts, 13(12), d394-d418. https://doi.org/10.56975/ijcrt.v13i12.296524
MLA — 9th edition
Isha, Gondaliya. "Comparative studies between clobazam and Carbamazepine." International Journal of Creative Research Thoughts, vol. 13, no. 12, 2025, pp. d394-d418, https://doi.org/10.56975/ijcrt.v13i12.296524.
Chicago — 17th, bibliography
Isha, Gondaliya. "Comparative studies between clobazam and Carbamazepine." International Journal of Creative Research Thoughts 13, no. 12 (2025): d394-d418. https://doi.org/10.56975/ijcrt.v13i12.296524.
Harvard — author–date
Isha, G. (2025) 'Comparative studies between clobazam and Carbamazepine', International Journal of Creative Research Thoughts, 13(12), pp. d394-d418. Available at: https://doi.org/10.56975/ijcrt.v13i12.296524
IEEE — numbered reference
G. Isha, "Comparative studies between clobazam and Carbamazepine," IJCRT, vol. 13, no. 12, pp. d394-d418, Dec. 2025, doi: 10.56975/ijcrt.v13i12.296524.
Vancouver — biomedical
Isha G. Comparative studies between clobazam and Carbamazepine. IJCRT. 2025 Dec;13(12):d394-d418. doi: 10.56975/ijcrt.v13i12.296524
AMA — 11th edition
Isha G. Comparative studies between clobazam and Carbamazepine. IJCRT. 2025;13(12):d394-d418. doi:10.56975/ijcrt.v13i12.296524
BibTeX — Zotero, Mendeley, LaTeX
@article{IJCRT2512390, author = {Gondaliya Isha}, title = {Comparative studies between clobazam and Carbamazepine}, journal = {International Journal of Creative Research Thoughts}, volume = {13}, number = {12}, pages = {d394-d418}, year = {2025}, month = {December}, issn = {2320-2882}, doi = {10.56975/ijcrt.v13i12.296524}, url = {https://doi.org/10.56975/ijcrt.v13i12.296524} }
RIS — EndNote, RefWorks
TY - JOUR AU - Isha, Gondaliya TI - Comparative studies between clobazam and Carbamazepine T2 - International Journal of Creative Research Thoughts JA - IJCRT VL - 13 IS - 12 PY - 2025 SN - 2320-2882 DO - 10.56975/ijcrt.v13i12.296524 UR - https://doi.org/10.56975/ijcrt.v13i12.296524 SP - d394-d418 ER -

Issue

Volume 13 Issue 12, December-2025
Pages : d394-d418

Article Information

Pages
d394-d418
Published
December 2025
Registration ID
IJCRT_296524
Published Paper ID
IJCRT2512390
Research Area
Pharmacy All
Author Type
Indian Author
Location
bhavnagar, gujarat, India
Licence
CC BY 4.0 · Open Access
ISSN & Impact Factor
2320-2882 · IF 9.17
Downloads
324
Crossmark

Check for updates. Crossmark shows whether this article has been corrected, updated or retracted since publication, and links to the current version of record.

Summarise this Paper with AI

Opens your assistant with a prepared prompt. AI summaries can be incomplete or wrong — read the full paper before citing it.

Share This Article

Author Services

Certificates, printed copies and official reports for this paper

Published authors can request a hard copy of their certificate or of the printed journal, and obtain the transparent peer review and plagiarism reports for this article — each issued against this paper’s registration record.

Registration ID IJCRT_296524

About Publisher

International Journal of Creative Research Thoughts Published by IJCRT Publication
2320-2882 ISSN
9.17 Impact Factor
2013 ESTD Year
Open Access
Impact Factor 9.17, calculated from Google Scholar citation data — see how it is worked out.
An international scholarly open access journal: peer-reviewed, refereed, multidisciplinary, monthly and multilingual, with Crossref DOI registration, rich metadata and a citation generator. Verified indexing & discovery records.
IJCRT is a Transparent, Peer-Reviewed, Open Access Journal (Refereed Journal). Following the discontinuation of UGC and UGC-CARE journal listing, IJCRT is aligned with UGC’s Suggested Parameters for Choosing Peer-Reviewed Journals. UGC Public Notice

Licence

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
 Disclaimer: The content, data and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses or consequences arising from its use.

Declarations

Funding

No external funding was received for this study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Acknowledgements

The authors would like to thank the reviewers and the editorial board of International Journal of Creative Research Thoughts for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.

About the Journal
9.17Impact Factor UGC AlignedSuggested Parameters TransparentPeer Review
Open AccessNo Paywall
CrossrefDOI Available
Monthly12 Issues / Year
Since 2013Established
2320-2882ISSN

Article Impact

65Views
49Downloads
114Total reads
Dec 2025Published
Published · 309 days ago Today · last read today
114 TOTAL
Views 65Downloads 49
75%
Readers who went on to take the PDF
Abstract views65
PDF downloads49

2.2 views and 1.7 downloads per day over 29 days counted.

Counts exclude identified crawler traffic and repeat hits from the same reader within 30 minutes. Downloads reached directly through a search engine or an existing citation link are not included, so the figure is a conservative count of activity through this site. Full statistics

Discovery & Indexing

Find this paper on search engines and scholarly indexes, and check the journal’s verified records.

Find this paperSearch
  • Google ScholarExact-title search, with citing articles once indexed.Search
  • CrossrefThe registered DOI record and its metadata.Open DOI record
  • Semantic ScholarAI-powered literature search.Search
  • BASEBielefeld Academic Search Engine — open-access harvester.Search
  • ResearchGateResearch network publication search.Search

“Search” opens a live search for this paper; “Verified” opens a journal record checked on the Indexing & Discovery page. Third-party services index at their own discretion, often several weeks after publication.

Research & Publication Timeline
Indexed, Abstracted & Author Benefits
Just ₹1501
Publish in a UGC CARE Approved Journal | Low Cost ₹1501 Indian Author | 🌐 $59 USD International
CrossRef DOI Google Scholar Transparent Review ISSN Registered 1–2 Days UGC CARE
Submit Paper →